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ABSTRACT Light activates rod outer segment (ROS)
phosphodiesterase (PDEase), as shown by previous biochemi-
cal and physiological studies. We have further investigated the
role of PDEase in this system by injecting trypsin-activated
PDEase, purified from bovine ROS, into single ROS of the
isolated retina of the toad Bufo marinus. Injection of about 300
molecules of activated PDEase in darkness is without immedi-
ate detectable effect, as measured by intracellular membrane-
voltage recording. The effect of the activated PDEase injec-
tions only becomes evident after illumination. The light re-
sponse is augmented; kinetics of repolarization are slowed. We
conclude that this augmentation of the light-dependent hyper-
polarization results from the hydrolysis of endogenous cyclic
GMP caused by injected PDEase. These results provide evi-
dence that PDEase affects light-dependent channels of the ver-
tebrate scotopic photoreceptors but do not specify whether the
effects are exercised for the initial hyperpolarizing phase of the
receptor potential and for the recovery phase or only for the
recovery phase.
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Light-mediated hydrolysis of cyclic GMP has been proposed
as an intermediate step in phototransduction in the verte-
brate retinal photoreceptors for dim light, the rods. Rod out-
er segments (ROS) contain a light-activated phosphodiester-
ase (PDEase) specific for cyclic GMP (1). A single photon
absorbed by a single molecule of rhodopsin can lead to the
activation of as many as 500 molecules of PDEase to hydro-
lyze >105 molecules of cyclic GMP per second (2). This high
degree of amplification is mediated by an intermediate pro-
tein, transducin, which carries the activation signal from
photolyzed rhodopsin to the PDEase (3).
Purified PDEase from ROS consists of a complex of a, (,
and y subunits, 88, 84, and 11 kilodaltons (kDa) in size (1).
Trypsin activates the PDEase by selectively degrading the y
inhibitory subunit, leaving the a and 8 subunits intact (4).
What is the role of cyclic GMP in transduction? Ionto-
phoretic injections of cyclic GMP depolarize the ROS and
increase the latency of the light-induced receptor potential as
if light-mediated cyclic GMP hydrolysis is necessary for pho-
totransduction (5, 6). Light-induced cyclic GMP-PDEase ac-
tivity is vigorous enough and its activation is rapid enough to
mediate the earliest phases of rod transduction (2, 7, 8). Pro-
tons released during hydrolysis of cyclic GMP also may reg-
ulate the receptor potential (9). However, Ca2+ can regulate
the ROS membrane potential, too. High Ca2+ concentrations
not only mimic the receptor potential (10) but also lower in-
tracellular cyclic GMP concentration (11). On the other
hand, cyclic GMP can regulate the Ca2+ distribution within
the cell by stimulating Ca2+ uptake by disks (12).
We have injected purified, trypsin-activated PDEase into
single ROS of the isolated toad retina to observe physiologi-
cal effects of increased hydrolysis of endogenous cyclic
21
14
FIG. 1. NaDodSO4/polyacrylamide gel electrophoresis of tryp-
sin-activated bovine retinal PDEase used for injection experiments.
Nine micrograms of activated PDEase was electrophoresed on
NaDodSO4/polyacrylamide gel made from 18% acrylamide/0.096%
bisacrylamide. The positions of standard proteins are marked. The
arrow indicates the position to which the 11-kDa y inhibitor subunit
has migrated in an adjacent lane. PDEase was extracted from bovine
ROS as described (4). It was purified by HPLC gel filtration on TSK
3000SW and concentrated. The y subunit was removed by digestion
with trypsin at 0°C (4), activating the PDEase. The PDEase was then
rechromatographed on the HPLC gel filtration column.
GMP. We find that such injections augment the light-induced
receptor potential.
METHODS AND MATERIALS
Cyclic GMP PDEase was extracted from bovine ROS mem-
branes, partially purified by gel filtration, activated by tryp-
sin, and purified to near homogeneity (Fig. 1) by gel filtration
Abbreviations: PDEase, phosphodiesterase; ROS, rod outer seg-
ment(s); kDa, kilodaltons.
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with a specific activity that ranged from 500 to 1,500 Amol/
min per mg assayed at 20'C (4). Bovine ROS PDEase inject-
ed into toad ROS should be functional because PDEase iso-
lated from retinas of a variety of species is indistinguishable
with respect to molecular weight and immunologically reac-
tive groups (13).
Purified activated PDEase was injected into ROS of the
isolated retinas of the toad Bufo marinus using pressure ap-
plied to the recording glass micropipette. The pipettes con-
tained -0.5 /.l of purified activated PDEase in 5 mM or 50
mM Tris HCl buffer (pH 8.0) or purified activated PDEase
in 20 mM 3-(N-morpholino)propanesulfonic acid/30 mM
NaCl/60 mM KCl/1 mM dithiothreitol/100 AM phenylmeth-
ylsulfonyl fluoride, pH 7.5. The concentration of activated
PDEase in the pipettes ranged from 0.05 to 1.8 mg/ml. The
upward-going spikes on the signal traces below the records
indicate light flashes illuminating the entire retinal patch in
the chamber with about 200 effective photons per flash per
rod. Down on the signal traces indicates the time during
which pressure is applied to the pipette.
RESULTS
Injected PDEase Augments Light-Dependent Hyperpolari-
zation. Fig. 2A shows responses to three light flashes, each
containing about 200 photons absorbed per rod. The second
flash is preceded by the 60-sec application of 7 bars (1 bar =
100 kPa) to the recording pipette, which contains 2.5 ,uM
activated PDEase in 50 mM Tris HCl (pH 8.0). The initial
hyperpolarizing phase caused by the first and last light
flashes is followed by a recovery phase lasting about 5 sec.
The response to the light flash delivered just after the
PDEase injection is augmented. The recovery phase is ex-
tended to about 3 min. The responses labeled 1 and 2 are
normalized, superimposed, and expanded in Fig. 2C. Re-
sponse 2 has a normal recovery time, even though the ROS
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is still hyperpolarized after the PDEase injection. Response
1 is expanded in Fig. 2B to show that the depolarization
caused by the PDEase injection in darkness has recovered
before the light flash is delivered.
Brief pressure injection pulses (Fig. 3) cause more pro-
nounced effects than prolonged injections (Fig. 2), possibly
because the pipette tip is more subject to clogging from pro-
longed pressure. Each brief pulse causes spike-like artifacts,
as shown on Fig. 3. After the train of 300-msec, 7-bar injec-
tions of PDEase (Fig. 3A), the light flash causes a response
that shows little recovery. The membrane potential contin-
ues to hyperpolarize to an absolute level of -57 mV after the
light response following the PDEase injections (Fig. 3A) and
shows no recovery in the further 10 min the cell is held, pos-
sibly reflecting the large amount of active PDEase injected in
this case. There are three types of controls: 1, the same in-
tensity light flash is delivered before and after the injection
as in Fig. 3A; 2, the same pipette is heated to 60'C for 15 min
to inactivate the PDEase and used for injections into other
ROS. No such injections augmented the light response, but it
is impossible to know whether the inactivated enzyme is ac-
tually injected into the cell; 3, the buffer vehicle alone is in-
jected as in Fig. 3B, where the pipette is loaded with 50 mM
Tris HCl. The train of 500-msec, 8-bar pulses causes a re-
versible depolarization without affecting the light response
that follows the injections.
Fig. 4A illustrates the effect of a single 200-msec, 4-bar
PDEase injection. Recovery of the light response after the
PDEase injection labeled 2 takes about 2 min compared to 5
sec for the controls before and after the injection. Responses
1 and 2 are expanded and superimposed on the trace in Fig.
4B to illustrate again (as in Figs. 2B and 3C) that there is
recovery to the base line after the PDEase injection. Thus,
the augmentation of the light response does not represent an
artifactual hyperpolarizing undershoot or rebound from the
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FIG. 2. (A) Sixty-second, 7-bar injection of 2.5 AtM purified, active PDEase into single ROS. Injection is preceded by a control light flash
and followed by light flashes labeled 1 and 2. Recovery of response 1 is inhibited without affecting response 2; (B) response 1 is expanded to
show that depolarization during injection recovers before light response commences; (C) responses 1 and 2 are expanded, normalized, and
superimposed to illustrate inhibition of recovery of response 1 after PDEase injection. Light flash intensities were about 200 effective photons
per ROS in A-C. Up on signal trace indicates light; down indicates pressure injection.
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FIG. 3. Comparison of effect of train of 300-msec, 7-bar injections of purified 2.5 ,uM PDEase in 50 mM Tris HCl buffer (pH 8) on light
response (A) with effect of train of 500-msec, 8-bar injections of buffer vehicle alone (B). Thirty seconds is excised from the trace in B between
the first flash and injections of buffer. (C) PDEase injections expanded to show recovery from depolarization during injections before light
response. Flash intensities were the same as for Fig. 2. Large spike transients during injections are artifacts.
pressure injection (neither do 300-msec pressure injections
of cyclic GMP, which cause transient depolarizations antag-
onized by light, cause any hyperpolarization undershoot).
The light flash that elicits the prolonged light-dependent hy-
perpolarization in Fig. 4 is delivered 7 sec after the 200-msec
PDEase injection and after recovery from the instability
caused by the injection (Fig. 4B). Seven seconds is sufficient
time for the injected PDEase to be incorporated into the sys-
tem and exert a light-dependent effect without causing a de-
tectable hyperpolarization in darkness. The base line can be
followed between pulses in the train in Fig. 3A. No sign of a
hyperpolarization is seen in the 12 sec before the flash in Fig.
3A that causes an 18-mV hyperpolarization lasting for min-
utes. Similarly, only a small depolarization is observed dur-
ing the 60-sec PDEase injection shown in Fig. 2. In contrast
to the lack of immediate detectable hyperpolarization attrib-
utable to injection of active PDEase in darkness, we observe
augmentation of light-dependent hyperpolarizations in 16
cells after the injection of purified activated PDEase, regard-
less of the buffer vehicle.
DISCUSSION
PDEase Appears to Affect Light-Dependent Channels. We
find that injection of trypsin-activated PDEase prolongs the
recovery phase of the voltage response to light. That injected
PDEase affects the light response is evidence that PDEase is
acting through the same molecular pathway as light. Yet, we
find these results to be puzzling and unexpected-puzzling
because the observations do not fit our preconception that
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FIG. 4. (A) Single 200-msec, 4-bar injection of purified activated PDEase into ROS produces an effect similar to that described for Figs. 2
and 3. (B) Responses 1 and 2 expanded to show effect of PDEase injection and illustrate that instability caused by the injection has subsided
before light response 1 commences. Light flash intensities and signal traces are described in the legend to Fig. 2.
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active PDEase would be expected to hydrolyze cyclic GMP
and directly lead to rapid hyperpolarization and unexpected
because a previous study (14) reports a reversible hyperpo-
larization during the injection in darkness of "partially puri-
fied, partially activated PDEase" and no prolongation of the
receptor potential. We cannot explain the difference be-
tween this previous report (14) and our results reported here.
Relation to Transduction Hypotheses. There are four major
transduction hypotheses:
Hypothesis 1. Ca2+ is released by light to block Na' con-
ductance. The mechanism of Ca2+ release by light is not
specified in this model. Cyclic GMP functions only to medi-
ate recovery after illumination by stimulating Ca2 uptake.
Light-activated PDEase slows the rate of Ca2+ uptake and
recovery (12).
Hypothesis 2. Cyclic GMP acting through a protein kinase
controls the state of phosphorylation of the Na' pore. Light-
activated PDEase lowers cyclic GMP to allow dephospho-
rylation activity of phosphatase to block Na' conductance
(15).
Hypothesis 3. Light-activated PDEase produces protons
via cyclic GMP hydrolysis. Protons exchange for Ca2+
which blocks the Na' conductance (9).
Hypothesis 4. A combination of hypotheses 2 and 3.
Both the failure to detect an immediate hyperpolarization
in the dark and the prolongation of the light response are
consistent with all of the hypotheses, assuming that a small
amount of PDEase is injected. We estimated the amount of
PDEase injected by comparing the effects of pressure injec-
tion of cyclic GMP to iontophoretic injection of cyclic GMP.
We find that 300-msec, 4-bar injections of 25 mM cyclic
GMP produce results equivalent to 5-pC current injections.
A 5-pC current pulse was previously estimated to increase
the dark ROS cyclic GMP concentration (6) by a third. This
is an estimate of the upper bound based on a transference
number of 1. The transference number for cyclic GMP is
more likely lower-e.g., 0.1. A 5-pC iontophoretic injection
then increases the dark ROS cyclic GMP concentration by
about 3%. Thus, a 200-msec, 4-bar injection of PDEase, us-
ing a pipette loaded with 2.5 .uM PDEase as in Fig. 4, corre-
sponds to an injected volume of 0.007% of the ROS volume
or about 300 molecules of PDEase.
One-picocoulomb iontophoretic pulses of cyclic GMP,
which may increase ROS cyclic GMP concentration by
0.6%, cause transient depolarizations lasting about a second
(6). Cyclic GMP depolarizations in more dark-adapted prep-
arations can be an order of magnitude slower, which implies
that both the dark hydrolysis and synthesis (cyclase) rates
may be about 9 ,uM/sec. An additional 300 active PDEases
would increase the dark rate by 8% and initially decrease
cyclic GMP concentration at a rate of 0.7 ,uM/sec, based on
a PDEase turnover number of 4,000 mol of cyclic GMP per
mol of PDEase (4). The dark cyclic GMP concentration
would be reduced from 50 ,M (16) to 44 uM in something
over 10 sec. The action of light would rapidly bring cyclic
GMP levels to the new steady state. The new steady state
would be prolonged while the return to normal dark cyclic
GMP concentration is postponed by the active PDEase,
which cannot be deactivated. A light response after the cell
has reached the altered steady state, as in (a) response 2 of
Fig. 2 and (b) the last response in Fig. 3A, would be followed
by a normal recovery to the same steady-state concentration
of cyclic GMP. Still, the lack of any immediate sign of hyper-
polarization after PDEase injections is not explained by the
steady-state model, although it is possible that the depolar-
ization artifact caused by injection tends to mask any slow
hyperpolarization. However, the failure to hyperpolarize in
darkness could be made consistent with hypotheses 2-4 by
assuming PDEase inactivation by excess inhibitor (4, 17),
only to be activated by illumination. Against this postulate
we find that purified PDEase assayed with homogenized
ROS in darkness in the ratio of purified PDEase to PDEase
in homogenized ROS of 1:20 and 1:200 does not significantly
alter enzymatic activity.
In the event that large amounts of active PDEase were
injected and the ROS cyclic GMP were to have been rapidly
and severely depleted without any physiological sign of hy-
perpolarization, the failure to hyperpolarize in the dark
would only be consistent with hypothesis 1.
Conclusion. Purified activated PDEase, injected into ROS,
augments the light-dependent hyperpolarization. Whatever
the mechanism by which the injected PDEase acts, its action
of augmenting the effects of light provides further evidence
that light-activated PDEase is part of the endogenous trans-
duction machinery.
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